Jan Stahlberg Insider Trading Activity

Corporate Insider10%+ Owner · CIK 1983161

17

Total trades

$19.0M

Total volume

Nov 25, 2025

Last activity

DMAC

DiaMedica Therapeutics Inc.

Jan Stahlberg has been net-buying over the last 12 months with 17 purchases and 0 sales across 1 company.

DMAC is the most-traded position with 17 trades. The largest single transaction was a purchase of DMAC for $5.4M on Jul 23, 2025.

Performance Scorecard

Forward stock performance after each transaction by Jan Stahlberg. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.

PERIODAVG BUY RETURNAVG SELL AVOIDEDSUCCESS RATETRADES
30 days+18.9%94%17
90 days+22.8%88%17
120 days+28.1%71%17

Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.

Price & Trades

Pro: Trade Markers

DMAC · DiaMedica Therapeutics Inc.

🔒 Subscribe to see trade entries

Pro members see exactly when Jan Stahlberg bought and sold DMAC.

Upgrade to Pro

Recent Trades

DATETICKERTYPESHARESPRICEVALUEROLE
Nov 25, 2025DMACBuy73,099$8.57$627K10%+ Owner
Nov 24, 2025DMACBuy40,253$7.89$318K10%+ Owner
Nov 21, 2025DMACBuy208,872$7.41$1.5M10%+ Owner
Nov 20, 2025DMACBuy128,426$7.41$951K10%+ Owner
Nov 19, 2025DMACBuy240,352$7.21$1.7M10%+ Owner
Nov 18, 2025DMACBuy182,882$6.75$1.2M10%+ Owner
Nov 17, 2025DMACBuy187,393$6.52$1.2M10%+ Owner
Aug 27, 2025DMACBuy50,772$6.00$305K10%+ Owner
Aug 26, 2025DMACBuy59,648$6.00$358K10%+ Owner
Aug 25, 2025DMACBuy338,265$6.00$2.0M10%+ Owner
Aug 22, 2025DMACBuy59,788$5.96$357K10%+ Owner
Aug 21, 2025DMACBuy48,172$5.96$287K10%+ Owner
Aug 20, 2025DMACBuy71,107$5.86$416K10%+ Owner
Aug 15, 2025DMACBuy8,233$6.00$49K10%+ Owner
Aug 14, 2025DMACBuy70,414$5.99$422K10%+ Owner
Aug 13, 2025DMACBuy293,601$5.91$1.7M10%+ Owner
Jul 23, 2025DMACBuy1,542,857$3.50$5.4M10%+ Owner

Top Companies Traded

TICKERCOMPANYTRADESTOTAL VOLUME
DMACDiaMedica Therapeutics Inc.17$19.0M